Cellectar Biosciences SG&A Expense (Quarterly) Insights

Cellectar Biosciences Inc (CLRB)

3.16 -0.04 (-1.25%) USD | NASDAQ | May 23, 10:28

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2005. Upgrade now.

Date	Value
March 31, 2024	4.624M
December 31, 2023	4.611M
September 30, 2023	2.101M
June 30, 2023	1.986M
March 31, 2023	2.051M
December 31, 2022	1.969M
September 30, 2022	2.435M
June 30, 2022	2.937M
March 31, 2022	2.253M
December 31, 2021	1.535M
September 30, 2021	1.882M
June 30, 2021	1.401M
March 31, 2021	1.726M
December 31, 2020	1.424M
September 30, 2020	1.226M
June 30, 2020	1.157M
March 31, 2020	1.342M
December 31, 2019	1.210M
September 30, 2019	1.26M
June 30, 2019	1.391M
March 31, 2019	1.321M
December 31, 2018	1.173M
September 30, 2018	1.092M
June 30, 2018	1.182M
March 31, 2018	1.330M

Date	Value
December 31, 2017	0.9887M
September 30, 2017	1.151M
June 30, 2017	1.040M
March 31, 2017	0.9554M
December 31, 2016	1.208M
September 30, 2016	1.162M
June 30, 2016	1.368M
March 31, 2016	0.9613M
December 31, 2015	0.7994M
September 30, 2015	0.8349M
June 30, 2015	0.8177M
March 31, 2015	0.9434M
December 31, 2014	0.855M
September 30, 2014	0.8028M
June 30, 2014	0.9599M
March 31, 2014	1.087M
December 31, 2013	1.406M
September 30, 2013	0.8436M
June 30, 2013	1.074M
March 31, 2013	1.122M
December 31, 2012	0.9366M
September 30, 2012	0.801M
June 30, 2012	0.8969M
March 31, 2012	0.9977M
December 31, 2011	0.8649M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.157M

Minimum

Jun 2020

4.624M

Maximum

Mar 2024

2.026M

Average

1.804M

Median

SG&A Expense (Quarterly) Benchmarks